{"entity":{"type":"insider","cik":"0001442730","url":"/insider/0001442730","json_url":"/insider/0001442730.json","name":"Geary Richard S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":107,"n_filings":56,"first":"2009-01-02","last":"2025-11-07","span_basis":"filed_date"},"name_variants":[{"name":"Geary Richard S","source":"filing","n_filings":56,"first_seen":"2009-01-02","last_seen":"2025-11-07"}],"transactions":[{"id":4191780,"accession":"0000874015-25-000277","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000874015-25-000277","line_url":"/filing/0000874015-25-000277","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33038.0,"shares_display":"33,038","price_per_share":75.72264766632362,"price_display":"75.72","price_state":"stated","total_value":2501724.8336,"total_display":"2,501,724.83","total_whole":"2,501,725","shares_owned_after":59657.0,"shares_owned_after_display":"59,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-06","filed_date":"2025-11-07","scope":"insider","n_lines":2},{"id":4191767,"accession":"0000874015-25-000277","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-25-000277","line_url":"/filing/0000874015-25-000277","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1601.0,"shares_display":"1,601","price_per_share":75.01,"price_display":"75.01","price_state":"stated","total_value":120091.01,"total_display":"120,091.01","total_whole":"120,091","shares_owned_after":59657.0,"shares_owned_after_display":"59,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-05","filed_date":"2025-11-07","scope":"insider","n_lines":2},{"id":9201501,"accession":"0000874015-25-000276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000276","line_url":"/filing/0000874015-25-000276","is_derivative":false,"issuer_cik":"0001442730","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0001442730","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1680.0,"shares_display":"1,680","price_per_share":75.054,"price_display":"75.05","price_state":"stated","total_value":126090.72,"total_display":"126,090.72","total_whole":"126,091","shares_owned_after":59657.0,"shares_owned_after_display":"59,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-07","scope":"insider","n_lines":2},{"id":5020892,"accession":"0000874015-25-000270","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000874015-25-000270","line_url":"/filing/0000874015-25-000270","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1680.0,"shares_display":"1,680","price_per_share":75.054,"price_display":"75.05","price_state":"stated","total_value":126090.72,"total_display":"126,090.72","total_whole":"126,091","shares_owned_after":59657.0,"shares_owned_after_display":"59,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-03","scope":"insider","n_lines":2},{"id":5020869,"accession":"0000874015-25-000270","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000874015-25-000270","line_url":"/filing/0000874015-25-000270","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89249.0,"shares_display":"89,249","price_per_share":75.1083,"price_display":"75.11","price_state":"stated","total_value":6703340.6667,"total_display":"6,703,340.67","total_whole":"6,703,341","shares_owned_after":79657.0,"shares_owned_after_display":"79,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-31","filed_date":"2025-11-03","scope":"insider","n_lines":3},{"id":4191755,"accession":"0000874015-25-000239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000239","line_url":"/filing/0000874015-25-000239#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57900.0,"shares_display":"57,900","price_per_share":65.2447,"price_display":"65.24","price_state":"stated","total_value":3777668.13,"total_display":"3,777,668.13","total_whole":"3,777,668","shares_owned_after":79657.0,"shares_owned_after_display":"79,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-01","scope":"insider"},{"id":4746243,"accession":"0000874015-25-000218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000218","line_url":"/filing/0000874015-25-000218#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.3671,"price_display":"50.37","price_state":"stated","total_value":503671.0,"total_display":"503,671.00","total_whole":"503,671","shares_owned_after":79657.0,"shares_owned_after_display":"79,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":4057881,"accession":"0000874015-25-000174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000174","line_url":"/filing/0000874015-25-000174#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.8593,"price_display":"42.86","price_state":"stated","total_value":428593.0,"total_display":"428,593.00","total_whole":"428,593","shares_owned_after":89492.0,"shares_owned_after_display":"89,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-05","filed_date":"2025-08-06","scope":"insider"},{"id":4225544,"accession":"0000874015-25-000076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000076","line_url":"/filing/0000874015-25-000076#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1406.0,"shares_display":"1,406","price_per_share":32.4049,"price_display":"32.40","price_state":"stated","total_value":45561.2894,"total_display":"45,561.29","total_whole":"45,561","shares_owned_after":99077.0,"shares_owned_after_display":"99,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-03","scope":"insider"},{"id":4161492,"accession":"0000874015-25-000059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000059","line_url":"/filing/0000874015-25-000059#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7072.0,"shares_display":"7,072","price_per_share":32.863,"price_display":"32.86","price_state":"stated","total_value":232407.136,"total_display":"232,407.14","total_whole":"232,407","shares_owned_after":96663.0,"shares_owned_after_display":"96,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":2884066,"accession":"0000874015-24-000191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000191","line_url":"/filing/0000874015-24-000191#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":331.0,"shares_display":"331","price_per_share":49.63,"price_display":"49.63","price_state":"stated","total_value":16427.53,"total_display":"16,427.53","total_whole":"16,428","shares_owned_after":84823.0,"shares_owned_after_display":"84,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-29","filed_date":"2024-09-03","scope":"insider"},{"id":2884061,"accession":"0000874015-24-000191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000191","line_url":"/filing/0000874015-24-000191#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":320.0,"shares_display":"320","price_per_share":49.16,"price_display":"49.16","price_state":"stated","total_value":15731.2,"total_display":"15,731.20","total_whole":"15,731","shares_owned_after":85154.0,"shares_owned_after_display":"85,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-09-03","scope":"insider"},{"id":2232316,"accession":"0000874015-24-000189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000189","line_url":"/filing/0000874015-24-000189#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2430.0,"shares_display":"2,430","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":116640.0,"total_display":"116,640.00","total_whole":"116,640","shares_owned_after":85508.0,"shares_owned_after_display":"85,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-06","scope":"insider"},{"id":9201499,"accession":"0000874015-24-000200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000200","line_url":"/filing/0000874015-24-000200#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1995.0,"shares_display":"1,995","price_per_share":50.0433,"price_display":"50.04","price_state":"stated","total_value":99836.3835,"total_display":"99,836.38","total_whole":"99,836","shares_owned_after":87300.0,"shares_owned_after_display":"87,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-09-04","scope":"insider"},{"id":2058791,"accession":"0000874015-24-000105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000105","line_url":"/filing/0000874015-24-000105#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1961.0,"shares_display":"1,961","price_per_share":50.0433,"price_display":"50.04","price_state":"stated","total_value":98134.9113,"total_display":"98,134.91","total_whole":"98,135","shares_owned_after":87334.0,"shares_owned_after_display":"87,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-02","scope":"insider"},{"id":2299301,"accession":"0000874015-24-000074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000074","line_url":"/filing/0000874015-24-000074#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7338.0,"shares_display":"7,338","price_per_share":50.417,"price_display":"50.42","price_state":"stated","total_value":369959.946,"total_display":"369,959.95","total_whole":"369,960","shares_owned_after":85475.0,"shares_owned_after_display":"85,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-18","scope":"insider"},{"id":8693810,"accession":"0000874015-23-000235","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-23-000235","line_url":"/filing/0000874015-23-000235#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4112.0,"shares_display":"4,112","price_per_share":49.2901,"price_display":"49.29","price_state":"stated","total_value":202680.8912,"total_display":"202,680.89","total_whole":"202,681","shares_owned_after":72961.0,"shares_owned_after_display":"72,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":8693806,"accession":"0000874015-23-000235","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000235","line_url":"/filing/0000874015-23-000235#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":49.6374,"price_display":"49.64","price_state":"stated","total_value":322643.1,"total_display":"322,643.10","total_whole":"322,643","shares_owned_after":72961.0,"shares_owned_after_display":"72,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-22","scope":"insider"},{"id":7833422,"accession":"0000874015-23-000227","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-23-000227","line_url":"/filing/0000874015-23-000227","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10613.0,"shares_display":"10,613","price_per_share":49.5841372185056,"price_display":"49.58","price_state":"stated","total_value":526236.4483,"total_display":"526,236.45","total_whole":"526,236","shares_owned_after":72961.0,"shares_owned_after_display":"72,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider","n_lines":2},{"id":8527255,"accession":"0000874015-23-000091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000091","line_url":"/filing/0000874015-23-000091#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1920.0,"shares_display":"1,920","price_per_share":40.6615,"price_display":"40.66","price_state":"stated","total_value":78070.08,"total_display":"78,070.08","total_whole":"78,070","shares_owned_after":72385.0,"shares_owned_after_display":"72,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-07","scope":"insider"},{"id":8278426,"accession":"0000874015-23-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000064","line_url":"/filing/0000874015-23-000064#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7873.0,"shares_display":"7,873","price_per_share":39.5688,"price_display":"39.57","price_state":"stated","total_value":311525.1624,"total_display":"311,525.16","total_whole":"311,525","shares_owned_after":70483.0,"shares_owned_after_display":"70,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":4506925,"accession":"0000874015-21-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-21-000025","line_url":"/filing/0000874015-21-000025#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Chief Development Offc)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Development Offc)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Development Offc","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141.0,"shares_display":"141","price_per_share":59.5,"price_display":"59.50","price_state":"stated","total_value":8389.5,"total_display":"8,389.50","total_whole":"8,390","shares_owned_after":30306.0,"shares_owned_after_display":"30,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-15","scope":"insider"},{"id":3073140,"accession":"0000874015-20-000156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-20-000156","line_url":"/filing/0000874015-20-000156#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Development)","role_mark":"O","role_mark_label":"Officer (EVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11920.0,"shares_display":"11,920","price_per_share":50.05,"price_display":"50.05","price_state":"stated","total_value":596596.0,"total_display":"596,596.00","total_whole":"596,596","shares_owned_after":30447.0,"shares_owned_after_display":"30,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-11-30","scope":"insider"},{"id":3308368,"accession":"0000874015-20-000148","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000874015-20-000148","line_url":"/filing/0000874015-20-000148#line-4","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Development)","role_mark":"O","role_mark_label":"Officer (EVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2380.0,"shares_display":"2,380","price_per_share":50.83,"price_display":"50.83","price_state":"stated","total_value":120975.4,"total_display":"120,975.40","total_whole":"120,975","shares_owned_after":30447.0,"shares_owned_after_display":"30,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-24","filed_date":"2020-11-25","scope":"insider"},{"id":3308361,"accession":"0000874015-20-000148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-20-000148","line_url":"/filing/0000874015-20-000148#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (EVP, Development)","role_mark":"O","role_mark_label":"Officer (EVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10700.0,"shares_display":"10,700","price_per_share":50.11,"price_display":"50.11","price_state":"stated","total_value":536177.0,"total_display":"536,177.00","total_whole":"536,177","shares_owned_after":30447.0,"shares_owned_after_display":"30,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"},{"id":8305524,"accession":"0000874015-19-000146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000146","line_url":"/filing/0000874015-19-000146#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":650000.0,"total_display":"650,000.00","total_whole":"650,000","shares_owned_after":21583.0,"shares_owned_after_display":"21,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-05","scope":"insider"},{"id":8223342,"accession":"0000874015-19-000142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-19-000142","line_url":"/filing/0000874015-19-000142#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":65.0574,"price_display":"65.06","price_state":"stated","total_value":325287.0,"total_display":"325,287.00","total_whole":"325,287","shares_owned_after":21583.0,"shares_owned_after_display":"21,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":8543029,"accession":"0000874015-19-000059","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000874015-19-000059","line_url":"/filing/0000874015-19-000059","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46240.0,"shares_display":"46,240","price_per_share":84.01282006920415,"price_display":"84.01","price_state":"stated","total_value":3884752.8,"total_display":"3,884,752.80","total_whole":"3,884,753","shares_owned_after":21442.0,"shares_owned_after_display":"21,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-10","scope":"insider","n_lines":3},{"id":7991325,"accession":"0000874015-19-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-19-000036","line_url":"/filing/0000874015-19-000036#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":999.0,"shares_display":"999","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":59940.0,"total_display":"59,940.00","total_whole":"59,940","shares_owned_after":21442.0,"shares_owned_after_display":"21,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-13","filed_date":"2019-02-14","scope":"insider"},{"id":6435233,"accession":"0000874015-18-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-18-000023","line_url":"/filing/0000874015-18-000023#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2723.0,"shares_display":"2,723","price_per_share":51.76,"price_display":"51.76","price_state":"stated","total_value":140942.48,"total_display":"140,942.48","total_whole":"140,942","shares_owned_after":16680.0,"shares_owned_after_display":"16,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-17","scope":"insider"},{"id":4836055,"accession":"0000874015-17-000061","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000874015-17-000061","line_url":"/filing/0000874015-17-000061","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8268.0,"shares_display":"8,268","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":496080.0,"total_display":"496,080.00","total_whole":"496,080","shares_owned_after":12351.0,"shares_owned_after_display":"12,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-13","filed_date":"2017-10-17","scope":"insider","n_lines":3},{"id":4727752,"accession":"0000874015-17-000010","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000874015-17-000010","line_url":"/filing/0000874015-17-000010","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2441.0,"shares_display":"2,441","price_per_share":46.29077918885702,"price_display":"46.29","price_state":"stated","total_value":112995.792,"total_display":"112,995.79","total_whole":"112,996","shares_owned_after":11150.0,"shares_owned_after_display":"11,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-18","scope":"insider","n_lines":4},{"id":3106430,"accession":"0000874015-16-000104","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000874015-16-000104","line_url":"/filing/0000874015-16-000104","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001442730","owner_name":"Geary Richard S","owner_display_name":"Geary Richard S","owner_url":"/insider/0001442730","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2162.0,"shares_display":"2,162","price_per_share":41.459040841813135,"price_display":"41.46","price_state":"stated","total_value":89634.4463,"total_display":"89,634.45","total_whole":"89,634","shares_owned_after":7524.0,"shares_owned_after_display":"7,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-19","filed_date":"2016-01-19","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":"2016-01-19|3106419","ledger_fault":false,"count":{"value":107,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":107,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":107},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Officer (EVP, Chief Development Officer)","n_filings":56,"first_seen":"2009-01-02","last_seen":"2025-11-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001442730","retrieved_at":"2026-08-26T16:07:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}